The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Endocrinología Diabetes y Nutrición

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.endinu.2017.03.006PMID 28495318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and cardiorenal syndrome: Understanding the "Triple Threat".

  2017cited by this paper
• Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse

  2017cited by this paper
• Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.

  2016cited by this paper
• Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin–angiotensin system

  2016cited by this paper
• Altered Nitric Oxide System in Cardiovascular and Renal Diseases

  2016cited by this paper
• Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

  2016cited by this paper
• Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study

  2016cited by this paper
• Targeting inflammation in diabetic kidney disease: early clinical trials

  2016cited by this paper
• Renin-angiotensin system within the diabetic podocyte.

  2015cited by this paper
• Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

  2015cited by this paper
• Endothelin Blockade in Diabetic Kidney Disease

  2015cited by this paper
• Inflammation in diabetic kidney disease.

  2014cited by this paper
• Therapeutic approaches to diabetic nephropathy—beyond the RAS

  2014cited by this paper
• Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

  2013cited by this paper
• To RAS or Not to RAS? The Evidence for and Cautions with Renin‐Angiotensin System Inhibition in Patients with Diabetic Kidney Disease

  2013cited by this paper
• An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.

  2013cited by this paper
• Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study

  2013cited by this paper
• Angiotensin-(1-7) in kidney disease: a review of the controversies.

  2012cited by this paper
• Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

  2008cited by this paper
• Enfermedad cardiovascular y función renal. Mecanismos patogénicos

  2008cited by this paper
• Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong

  2008cited by this paper
• Bloqueo del sistema renina-angiotensina-aldosterona en hipertensión arterial, diabetes y nefropatía

  2008cited by this paper
• Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

  2002cited by this paper
• Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

  2002cited by this paper
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000cited by this paper
• The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.

  1997cited by this paper
• Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study

  1996cited by this paper

• Expression of the Renin-Angiotensin System in the Heart, Aorta, and Perivascular Adipose Tissue in an Animal Model of Type 1 Diabetes

  2025cites this paper
• Type 2 diabetes mellitus: Isn’t it time to update the terminology?

  2025cites this paper
• Diabetes in spotlight: current knowledge and perspectives of photobiomodulation utilization

  2024cites this paper
• The need for adjusting experimental models to meet clinical reality.

  2022cites this paper
• Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes.

  2021influential citation
• World Journal of Diabetes

  year unknowncites this paper